# Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles

> **NCT00655356** · PHASE3 · COMPLETED · sponsor: **Castle Creek Biosciences, LLC.** · enrollment: 218 (actual)

## Conditions studied

- Bilateral Nasolabial Fold Wrinkles

## Interventions

- **BIOLOGICAL:** Autologous Human Fibroblasts (azficel-T)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00655356
- **Lead sponsor:** Castle Creek Biosciences, LLC.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-07
- **Final completion:** 2009-05
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2012-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655356, "Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00655356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*